Evidence of brain tumor stem progenitor-like cells with low proliferative capacity in human benign pituitary adenoma

Cancer Letters

Volumn 349, Issue 1, 2014, Pages 61-66

  Chen, Lingchao ^a   Ye, Hongxing ^b   Wang, Xiaomei ^c   Tang, Xuqung ^a   Mao, Ying ^a   Zhao, Yao ^a   Wu, Zhebao ^d   Mao, Xiao Ou ^e   Xie, Lin ^e   Jin, Kunlin ^f   Yao, Yu ^a  

^a FUDAN UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY   (China)

^c TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^d SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^e BUCK INSTITUTE FOR RESEARCH ON AGING   (United States)

^f UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

Author keywords

Benign tumor; Brain; Pituitary adenoma; Tumor stem progenitor cells

Indexed keywords

CD133 ANTIGEN; CELL MARKER; KI 67 ANTIGEN; GLYCOPROTEIN; LEUKOCYTE ANTIGEN; PEPTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; BRAIN TUMOR; CANCER STEM CELL; CARCINOGENICITY; CELL DIFFERENTIATION; CELL INVASION; CELL LINEAGE; CELL PROLIFERATION; CELL SUBPOPULATION; CONTROLLED STUDY; DAUGHTER CELL; DISEASE ACTIVITY; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; HYPOPHYSIS ADENOMA; IMMUNOCYTOCHEMISTRY; MAJOR CLINICAL STUDY; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR INVASION; ADENOMA; CELL GROWTH; HYPOPHYSIS TUMOR; METABOLISM; NEURAL STEM CELL; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE;

ADENOMA; ANTIGENS, CD; BRAIN NEOPLASMS; CELL GROWTH PROCESSES; CELL LINE, TUMOR; GLIOBLASTOMA; GLYCOPROTEINS; HUMANS; NEOPLASTIC STEM CELLS; NEURAL STEM CELLS; PEPTIDES; PITUITARY NEOPLASMS;

EID: 84901022007     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2014.03.031     Document Type: Article

References (31)

1. Reya T., Morrison S.J., Clarke M.F., Weissman I.L. Stem cells, cancer, and cancer stem cells. Nature 2001, 414:105-111.
2. Huntly B.J., Gilliland D.G. Leukaemia stem cells and the evolution of cancer-stem-cell research. Nat. Rev. Cancer 2005, 5:311-321.
3. Al-Hajj M., Wicha M.S., Benito-Hernandez A., Morrison S.J., Clarke M.F. From the cover: prospective identification of tumorigenic breast cancer cells. PNAS 2003, 100:3983-3988.
4. Singh S.K., Clarke I.D., Terasaki M., Bonn V.E., Hawkins C., Squire J., Dirks P.B. Identification of a cancer stem cell in human brain tumors. Cancer Res. 2003, 63:5821-5828.
5. Singh S.K., Hawkins C., Clarke I.D., Squire J.A., Bayani J., Hide T., Henkelman R.M., Cusimano M.D., Dirks P.B. Identification of human brain tumour initiating cells. Nature 2004, 432:396-401.
6. Uchida N., Buck D.W., He D., Reitsma M.J., Masek M., Phan T.V., Tsukamoto A.S., Gage F.H., Weissman I.L. Direct isolation of human central nervous system stem cells. Proc. Nat. Acad. Sci. U.S.A. 2000, 97:14720-14725.
7. Patrawala L., Calhoun T., Schneider-Broussard R., Zhou J., Claypool K., Tang D.G. Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2+ and ABCG2- cancer cells are similarly tumorigenic. Cancer Res. 2005, 65:6207-6219.
8. Reynolds B.A., Weiss S. Clonal and population analyses demonstrate that an EGF-responsive mammalian embryonic CNS precursor is a stem cell. Develop. Biol. 1996, 175:1-13.
9. Bonnet D., Dick J.E. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat. Med. 1997, 3:730-737.
10. Singh S.K., Clarke I.D., Hide T., Dirks P.B. Cancer stem cells in nervous system tumors. Oncogene 2004, 23:7267-7273.
11. Kleihues P., Louis D.N., Scheithauer B.W., Rorke L.B., Reifenberger G., Burger P.C., Cavenee W.K. The WHO classification of tumors of the nervous system. J. Neuropathol. Exp. Neurol. 2002, 61:215-225. (Discussion 226-219).
12. Yao Y., Tao R., Wang X., Wang Y., Mao Y., Zhou L.F. B7-H1 is correlated with malignancy-grade gliomas but is not expressed exclusively on tumor stem-like cells. Neuro-oncology 2009, 11:757-766.
13. Jin K., Peel A.L., Mao X.O., Xie L., Cottrell B.A., Henshall D.C., Greenberg D.A. Increased hippocampal neurogenesis in Alzheimer's disease. PNAS 2004, 101:343-347.
14. Jin K., Mao X., Sun Y., Xie L., Greenberg D. Stem cell factor stimulates neurogenesis in vitro and in vivo. J. Clin. Invest. 2002, 110:311-319.
15. Jin K., Mao X.O., Sun Y., Xie L., Jin L., Nishi E., Klagsbrun M., Greenberg D.A. Heparin-binding epidermal growth factor-like growth factor: hypoxia-inducible expression in vitro and stimulation of neurogenesis in vitro and in vivo. J. Neurosci. 2002, 22:5365-5373.
16. Kaneko Y., Sakakibara S., Imai T., Suzuki A., Nakamura Y., Sawamoto K., Ogawa Y., Toyama Y., Miyata T., Okano H. Musashi1: an evolutionally conserved marker for CNS progenitor cells including neural stem cells. Dev. Neurosci. 2000, 22:139-153.
17. Lee J.E., Hollenberg S.M., Snider L., Turner D.L., Lipnick N., Weintraub H. Conversion of Xenopus ectoderm into neurons by NeuroD, a basic helix-loop-helix protein. Science 1995, 268:836-844.
18. Rousselot P., Lois C., Alvarez-Buylla A. Embryonic (PSA) N-CAM reveals chains of migrating neuroblasts between the lateral ventricle and the olfactory bulb of adult mice. J. Comp. Neurol. 1995, 351:51-61.
19. Miraglia S., Godfrey W., Yin A.H., Atkins K., Warnke R., Holden J.T., Bray R.A., Waller E.K., Buck D.W. A novel five-transmembrane hematopoietic stem cell antigen: isolation, characterization, and molecular cloning. Blood 1997, 90:5013-5021.
20. Minturn J.E., Fryer H.J., Geschwind D.H., Hockfield S. TOAD-64, a gene expressed early in neuronal differentiation in the rat, is related to unc-33, a C. elegans gene involved in axon outgrowth. J. Neurosci.: Official J. Soc. Neurosci. 1995, 15:6757-6766.
21. Thapar K., Kovacs K., Laws E.R. The classification and molecular biology of pituitary adenomas. Adv. Tech. Stand. Neurosurg. 1995, 22:3-53.
22. Hemmati H.D., Nakano I., Lazareff J.A., Masterman-Smith M., Geschwind D.H., Bronner-Fraser M., Kornblum H.I. Cancerous stem cells can arise from pediatric brain tumors. PNAS 2003, 100:15178-15183.
23. Yunoue S., Arita K., Kawano H., Uchida H., Tokimura H., Hirano H. Identification of CD133+ cells in pituitary adenomas. Neuroendocrinology 2011, 94:302-312.
24. Xu Q., Yuan X., Tunici P., Liu G., Fan X., Xu M., Hu J., Hwang J.Y., Farkas D.L., Black K.L., Yu J.S. Isolation of tumour stem-like cells from benign tumours. Br. J. Cancer 2009, 101:303-311.
25. Tunici P., Yu J.S. Pituitary adenoma stem cells. Methods Mol. Biol. 2009, 568:195-201.
26. Isono M., Inoue R., Kamida T., Kobayashi H., Matsuyama J. Significance of leptin expression in invasive potential of pituitary adenomas. Clin. Neurol. Neurosurg. 2003, 105:111-116.
27. Karga H.J., Alexander J.M., Hedley-Whyte E.T., Klibanski A., Jameson J.L. Ras mutations in human pituitary tumors. J. Clin. Endocrinol. Metab. 1992, 74:914-919.
28. Ikeda H., Yoshimoto T. The relationship between c-myc protein expression, the bromodeoxyuridine labeling index and the biological behavior of pituitary adenomas. Acta Neuropathol. 1992, 83:361-364.
29. Buckley N., Bates A.S., Broome J.C., Strange R.C., Perrett C.W., Burke C.W., Clayton R.N. P53 Protein accumulates in Cushings adenomas and invasive non-functional adenomas. J. Clin. Endocrinol. Metab. 1994, 79:1513-1516.
30. Hentschel S.J., Mccutcheon E., Moore W., Durity F.A. P53 and MIB-1 immunohistochemistry as predictors of the clinical behavior of nonfunctioning pituitary adenomas. Can. J. Neurol. Sci. Le journal canadien des sciences neurologiques 2003, 30:215-219.
31. Pei L., Melmed S., Scheithauer B., Kovacs K., Benedict W.F., Prager D. Frequent loss of heterozygosity at the retinoblastoma susceptibility gene (RB) locus in aggressive pituitary tumors: evidence for a chromosome 13 tumor suppressor gene other than RB. Cancer Res. 1995, 55:1613-1616.